Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2008
12/30/2008US7470528 DNA encoding hydroxylase
12/30/2008US7470521 fusion proteins comprising a Receptor for Advanced Glycation Endproducts; treating a condition characterized by activation of an inflammatory cytokine cascade comprising administering such fusion proteins
12/30/2008US7470516 oligonucleotides used for detection and analyzing analytes in solution
12/30/2008US7470515 Reverse transcription of nucleic acid molecules comprising incubating templates in a buffer comprising transcriptase, primers and oligomers
12/30/2008US7470512 Hybrid analyzing; amplification primers
12/30/2008US7470510 Methods for diagnosing cancer and determining a susceptibility for developing cancer
12/30/2008US7470508 Screening for melanoma in skin sample; obtain skin extract nucleotide sequences, incubate with cyclin sequence probe, determine concentration of bound probe, compare to control, evaluate for skin melanoma
12/30/2008US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization
12/30/2008CA2409523C Method for increasing the hybridization rate of nucleic acids
12/30/2008CA2348413C Detection of human papilloma virus in papanicolaou (pap) smears
12/30/2008CA2247545C Method of isolation of primer extension products with modular oligonucleotides
12/30/2008CA2246259C Genetic markers and methods for the detection of escherichia coli serotype-0157:h7
12/30/2008CA2244891C Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
12/30/2008CA2219807C Systematic evolution of ligands by exponential enrichment: tissue selex
12/30/2008CA2218929C Compositions in glassy phase, stabilised by a sugar
12/25/2008US20080320616 Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
12/25/2008US20080320612 Vascular-preferred promoter sequences and uses thereof
12/25/2008US20080319184 Uses of Dinucleotide Polyphosphate Derivatives
12/25/2008US20080319182 Isolation and purification of nucleic acids with a solid phase
12/25/2008US20080319181 Method of Making an Artificial Nuclease for Anti-viral, Anti-bacterial Applications
12/25/2008US20080319180 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents
12/25/2008US20080319179 A nucleotide having a base attached to a detectable label through a cleavable linker; has a deoxyribose comprising a cleavable chemical group capping the 3' OH group of the deoxyribose and wherein both the cleavable linker and the capping cleavable chemical group are cleavable by light
12/25/2008US20080319177 Recombinase-expressing cells
12/25/2008US20080319176 Glycerol as a predictor of glucose tolerance
12/25/2008US20080319167 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
12/25/2008US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
12/25/2008US20080318894 Rna antagonist compounds for the modulation of her3
12/25/2008US20080318891 Antisense oligonucleotides against thymidylate synthase
12/25/2008US20080318884 Methods for Altering Gene Expression and Methods of Treatment Utilizing Same
12/25/2008US20080318858 comprises a modified amino acid sequence comprising one or more amino acid substitutions to an amino acid sequence; substitutions are selected from the group consisting of H98Y, E102K, E108K, E120K; use as complement inhibitor
12/25/2008US20080318857 Compositions and Methods for the Intracellular Disruption of Vegf and Vegfr-2 By Intraceptors
12/25/2008US20080318855 Dna encoding for recombinant polypeptide emutants of human stromal cell-derived factor 1
12/25/2008US20080318835 Novel Integrin Ligand ITGL-TSP
12/25/2008US20080318806 Device for chemical and biochemical reactions using photo-generated reagents
12/25/2008US20080318803 Biomarkers for Monitoring Impdh Pathway Inhibition
12/25/2008US20080318790 Process for the Production of Fine Chemicals
12/25/2008US20080318329 Liquid crystal condensation of nucleic acid (na) complexes
12/25/2008US20080318297 Inhibition of Infiltration, and Cell Killing Agent
12/25/2008US20080318296 Mutant Glycoprotein Resistant to Modification with Asparagine-Linked Sugar Chain
12/25/2008US20080318295 capable of reducing or converting the compound I-[4-(4-fluoro2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-propan-2-one to the corresponding product (R) 1-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-propan-2-
12/25/2008US20080318286 P1-35 Expression Units
12/25/2008US20080318278 Ammonia-Specific 5'-Xmp Aminase Mutant
12/25/2008US20080318276 Human Coagulation Factor VII Variants
12/25/2008US20080318273 Mutant proteinase with reduced self-cleavage activity and method of purification
12/25/2008US20080318271 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains
12/25/2008US20080318257 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits
12/25/2008US20080318226 Signal Amplification Method
12/25/2008US20080318217 Identification of Gene Associated with Reading Disability and Uses Therefor
12/25/2008US20080318210 Bioinformatically detectable group of novel regulatory viral and viral associated oligonucleotides and uses thereof
12/25/2008US20080318205 Hiv Type and Subtype Detection
12/25/2008US20080317783 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
12/25/2008US20080317782 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction
12/25/2008US20080317777 Cdna Construct Of Salmonidae Alphavirus
12/25/2008US20080317768 Bioconjugated nanoparticles
12/25/2008US20080317762 Bacterial Contact Inhibition and Methods Therefor
12/25/2008US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity
12/25/2008US20080317758 Polypeptide variants with altered effector function
12/25/2008US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer
12/25/2008US20080317754 Human Osteoclast Derived Cathepsin
12/25/2008US20080317746 Anti-Il2 Antibodies
12/25/2008US20080317722 Methods and Compositions Involving Developmental Decision Promoter Regions
12/25/2008US20080317717 Anti-hepatitis b virus ribozymal nucleic acid
12/25/2008US20080317669 Cloning of honey bee allergen C
12/24/2008WO2008157696A2 High throughput nucleic acid sequencing by expansion
12/24/2008WO2008157572A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments
12/24/2008WO2008157319A1 ONCOGENIC ALL-1 FUSION PROTEINS FOR TARGETING DROSHA-MEDIATED microRNA PROCESSING
12/24/2008WO2008157311A2 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same
12/24/2008WO2008157264A2 Combined methods for the detection of chromosomal aneuploidy
12/24/2008WO2008156858A2 Use of pre-mrna splicing in platelet cells for the diagnosis of disease
12/24/2008WO2008156753A1 Early intervention of viral infections with immune activators
12/24/2008WO2008138001A3 Synthetic peptides and peptide mimetics
12/24/2008WO2008131006A3 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
12/24/2008WO2008130985A3 Plants with multiple transgenes on a chromosome
12/24/2008WO2008130585A9 Wireframe nanostructures
12/24/2008WO2008127453A3 Nucleic acid-based translation system and method for decoding nucleic acid encrypted message
12/24/2008WO2008124119A9 Improved methods and compositions for determining the pathogenic status of infectious agents
12/24/2008WO2008121444A3 Genetic methods for speciating campylobacter
12/24/2008WO2008118877A3 Method of diagnosing, classifying and treating endometrial cancer and precancer
12/24/2008WO2008118469A3 Genetics variants associated with hiv disease restriction
12/24/2008WO2008112154A3 Methods of using genomic biomarkers to predict tumor formation
12/24/2008WO2008103135A3 The micrornaome
12/24/2008WO2008101234A8 Anti ganglioside gd3 antibodies and uses thereof
12/24/2008WO2008098198A3 Alkane oxidation by modified hydroxylases
12/24/2008WO2008091679A3 Method and kit for detection of mbcr/abl gene fusion and c-kit (cd117)
12/24/2008WO2008086807A3 Mediated cellular delivery of lna oligonucleotides
12/24/2008WO2008076449A3 Predicting a response to olanzapine
12/24/2008WO2008073615A9 N-glycosylation mutant of melanoma differentiation associated gene-7
12/24/2008WO2008066871A3 Nucleic acid probes and methods for detecting plasmodium parasites
12/24/2008WO2008066608A8 A secreted luciferase fluorescent protein conjugate nucleic acid construct and uses thereof
12/24/2008WO2008063783A3 Biomarkers related to metabolic age and methods using the same
12/24/2008WO2008057545A3 Gene expression profiling based identification of genomic signatures of high-risk multiple myeloma and uses thereof
12/24/2008WO2008055196A3 Genemap of the human genes associated with male pattern baldness
12/24/2008WO2008051604A3 Methods and compositions for determining whether a subject carries a disease associated gene mutation common in jewish populations
12/24/2008WO2008048570A3 Piwil2-related biomarkers and cell lines useful therewith
12/24/2008WO2008036350A3 Aldehyde tags, uses thereof in site-specific protein modification
12/24/2008WO2008014521A3 Improved vaccines and methods for using the same
12/24/2008WO2008014008A3 Compositions and methods for modulating angiogenesis
12/24/2008WO2008013910A3 Methods for identifying, diagnosing, and predicting survival of lymphomas
12/24/2008WO2008008553A3 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
12/24/2008WO2008006028A3 Chimeric zinc finger recombinases optimized for catalysis by directed evolution